drugset / Trial / NCT06116890
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with nAMD.
Timeline
- Start
- 2024-01-31
- Primary completion
- 2026-08-31
- Completion
- 2026-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KHK4951 | Unknown | — | Other |
| Background | Aflibercept | Protein / enzyme biologic | — | Intravitreal |